European scientists target high-risk childhood cancer with liquid biopsy
Liquid biopsies are a promise for the future of personalized cancer medicine: Many children with high-risk neuroblastoma, i.e. 50 percent of all neuroblastoma cases, are at risk of not responding to therapy and developing a recurrence.